System for providing fluid flow to nerve tissues
View Patent ↗Provided is an apparatus that includes a nerve conduit and a nested manifold for providing a reduced pressure. Also provided is a system that includes a source of reduced pressure, a nerve conduit and nested manifold, and a conduit for providing fluid communication between the manifold and the source of reduced pressure. Additionally provided is a method that includes implanting the above nerve conduit and manifold at a site of damaged nerve tissue and applying a reduced pressure to the manifold thereby stimulating repair or regrowth of nerve tissue.
1. An apparatus for providing reduced pressure to a defect at a tissue site of a nerve, the apparatus comprising:
a nerve conduit having a luminal wall for surrounding the tissue site and forming a luminal space between the tissue site and the luminal wall;
a manifold having a connector for receiving reduced pressure to distribute the reduced pressure to the defect; and
a scaffold formed from a bioabsorbable material, the scaffold having:
pores that are sufficiently small to bind cells and proteins,
a generally tubular frustum shape extending between a base opening at one end and a vertex opening at the other end,
at least one fiber guide extending through the luminal space and the vertex opening of the scaffold that is adapted to be in fluid communication with the tissue site of the nerve, and
the scaffold being positioned within the luminal space with the vertex opening oriented closer to the manifold.
2. The apparatus of claim 1 , wherein the defect is a severed nerve.
3. The apparatus of claim 1 , wherein the defect is a pinched, partially severed, or degenerative nerve extending through the vertex opening of the scaffold.
4. The apparatus of claim 1 , wherein the scaffold is composed of a hydrophobic or a hydrophilic material.
5. The apparatus of claim 1 , wherein the at least one fiber guide is in fluid communication with the manifold and the scaffold.
6. The apparatus of claim 1 , wherein the at least one fiber guide comprises fibrous protrusions extending into the luminal space.
7. The apparatus of claim 1 , wherein the at least one fiber guide is generally linear.
8. The apparatus of claim 1 , wherein the at least one fiber guide is bioabsorbable.
9. The apparatus of claim 8 , wherein the at least one fiber guide is comprised of collagen or fibrin.
10. The apparatus of claim 1 , wherein the manifold is positioned adjacent the distal side of the nerve.
11. The apparatus of claim 1 , wherein the manifold provides reduced pressure preferentially to the distal side of the nerve.
12. The apparatus of claim 1 , wherein the manifold is composed of a bioinert or bioabsorbable material.
13. The apparatus of claim 1 , wherein the manifold is substantially tubular or cylindrical in shape and positioned within the luminal space.
14. The apparatus of claim 1 , wherein the manifold extends through the wall of the nerve conduit in fluid communication with the luminal space.
15. The apparatus of claim 1 , wherein the scaffold is formed from a foam or gel material.
16. The apparatus of claim 1 , wherein the scaffold comprises a bioactive agent.
17. The apparatus of claim 16 , wherein the bioactive agent is at least one of an antibiotic, an antibody and a growth factor.
18. The apparatus of claim 16 , wherein the bioactive agent is a growth hormone (GH), a bone morphogenetic protein (BMP), transforming growth factor-α (TGF-α), a TGF-β, a fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte/macrophage-colony stimulating factor (GM-CSF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF), an interleukin, tumor necrosis factor-α (TNF-α) or nerve growth factor (NGF).
19. The apparatus of claim 1 , wherein the nerve conduit comprises a slice along its length that forms an opening whereby the nerve conduit is implantable around the tissue site and sealable with one or more closure elements.
20. The apparatus of claim 1 , wherein the nerve conduit is composed of a bioinert material.
21. The apparatus of claim 1 , wherein the nerve conduit is composed of a bioabsorbable material.
22. The apparatus of claim 21 , wherein the nerve conduit is composed of collagen.
23. The apparatus of claim 1 , wherein the nerve conduit comprises pores.
24. The apparatus of claim 23 , wherein the pores are sufficiently small to exclude the entry of cells from tissue surrounding the nerve conduit into the luminal space.
25. The apparatus of claim 24 , wherein the pores have a diameter of between about 5 μm and about 50 μm.
26. The apparatus of claim 1 , wherein the manifold is in fluid communication with the scaffold.
27. An apparatus for providing reduced pressure to a defect at a tissue site of a nerve, the apparatus comprising:
a nerve conduit having a generally tubular shape and having a luminal wall for surrounding the tissue site to contain fluids within a luminal space between the tissue site and the luminal wall;
a manifold having a connector for receiving reduced pressure to distribute the reduced pressure to the defect; and
a scaffold formed from a bioabsorbable material and comprising:
at least one scaffold guide having pores that are sufficiently small to collect cells and a generally frusto-tubular shape with a base opening at one end and a vertex opening at the other end, the at least one scaffold guide is positioned within the luminal space in fluid communication with the manifold and oriented therein with the vertex opening positioned closer to the manifold than the base opening,
at least one fiber guide extending generally longitudinally through the luminal space and the vertex opening of the at least one scaffold guide and is adapted to be in fluid communication with the tissue site of the nerve;
whereby the at least one scaffold guide facilitates tissue growth at the tissue site by organizing matrix deposition, promoting cell binding, or guiding the migration of cells through the luminal space.
28. The apparatus of claim 27 , wherein the defect is a severed nerve.
29. The apparatus of claim 27 , wherein the defect is a pinched, partially severed, or degenerative nerve extending through the vertex opening of the at least one scaffold guide.
30. The apparatus of claim 27 , wherein the at least one scaffold guide is composed of a hydrophobic material.
31. The apparatus of claim 27 , wherein the at least one fiber guide is in fluid communication with the manifold and the at least one scaffold guide.
32. The apparatus of claim 27 , wherein the at least one fiber guide comprises fibrous protrusions extending into the luminal space.
33. The apparatus of claim 27 , wherein the at least one fiber guide is generally linear.
34. The apparatus of claim 27 , wherein the at least one fiber guide is bioabsorbable.
35. The apparatus of claim 34 , wherein the at least one fiber guide is comprised of collagen or fibrin.
36. The apparatus of claim 27 , wherein the manifold is positioned adjacent the distal side of the nerve.
37. The apparatus of claim 27 , wherein the manifold provides reduced pressure preferentially to the distal side of the nerve.
38. The apparatus of claim 27 , wherein the manifold is composed of a bioinert or bioabsorbable material.
39. The apparatus of claim 27 , wherein the manifold is substantially tubular or cylindrical in shape and positioned within the luminal space of the nerve conduit.
40. The apparatus of claim 27 , wherein the manifold extends through the wall of the nerve conduit in fluid communication with the luminal space.
41. The apparatus of claim 27 , wherein the scaffold is formed from a foam or gel material.
42. The apparatus of claim 27 , wherein the scaffold comprises a bioactive agent.
43. The apparatus of claim 42 , wherein the bioactive agent is at least one of an antibiotic, an antibody and a growth factor.
44. The apparatus of claim 42 , wherein the bioactive agent is a growth hormone (GH), a bone morphogenetic protein (BMP), transforming growth factor-α (TGF-α), a TGF-β, a fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte/macrophage-colony stimulating factor (GM-CSF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF), an interleukin, tumor necrosis factor-α (TNF-α) or nerve growth factor (NGF).
45. The apparatus of claim 27 , wherein the nerve conduit comprises a slice along its length that forms an opening whereby the nerve conduit is implantable around the tissue site and sealable with one or more closure elements.
46. The apparatus of claim 27 , wherein the nerve conduit is composed of a bioinert material.
47. The apparatus of claim 27 , wherein the nerve conduit is composed of a bioabsorbable material.
48. The apparatus of claim 47 , wherein the nerve conduit is composed of collagen.
49. The apparatus of claim 27 , wherein the nerve conduit comprises pores.
50. The apparatus of claim 49 , wherein the pores are sufficiently small to exclude the entry of cells from tissue surrounding the nerve conduit into the luminal space.
51. The apparatus of claim 50 , wherein the pores have a diameter of between about 5 μm and about 50 μm.